Search Results - "Staller, Peter"
-
1
The KDM5 family of histone demethylases as targets in oncology drug discovery
Published in Epigenomics (01-06-2014)“…There is growing evidence for a causal role of the KDM5 family of histone demethylases in human cancer. In particular, KDM5A (JARID1A/RBP2) and KDM5B…”
Get more information
Journal Article -
2
The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF
Published in The Journal of biological chemistry (26-12-2008)“…Posttranslational histone modifications serve to store epigenetic information and control both nucleosome assembly and recruitment of non-histone proteins…”
Get full text
Journal Article -
3
FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function
Published in The EMBO journal (16-11-2011)“…Exposure of metazoan organisms to hypoxia engages a metabolic switch orchestrated by the hypoxia‐inducible factor 1 (HIF‐1). HIF‐1 mediates induction of…”
Get full text
Journal Article -
4
HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases
Published in Oncogene (01-04-2019)“…Targeting of histone methylation has therapeutic potential in oncology. Here, we provide proof-of-principle that pharmacological inhibition of KDM5…”
Get full text
Journal Article -
5
The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover
Published in Nucleic acids research (01-04-2013)“…The androgen receptor (AR) is a key molecule involved in prostate cancer (PC) development and progression. Post-translational modification of the AR by…”
Get full text
Journal Article -
6
Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL
Published in Nature (18-09-2003)“…Organ-specific metastasis is governed, in part, by interactions between chemokine receptors on cancer cells and matching chemokines in target organs. For…”
Get full text
Journal Article -
7
Abstract A29: Genome-wide CRISPR/Cas9 screens for the identification of novel YAP1/TAZ modulators
Published in Molecular cancer research (01-08-2020)“…Abstract Aberrant activation of the Hippo pathway effectors YAP1/TAZ promotes cell proliferation and tumorigenesis. To identify novel regulators of YAP1/TAZ in…”
Get full text
Journal Article -
8
Abstract 6089: Identification of novel YAP/TAZ pathway regulators in the triple-negative breast cancer cell line MDA-MB231 using single-cell CRISPR screening
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract The Hippo signaling cascade is a major pathway that integrates a broad spectrum of mechanosensory signals at the plasma membrane and regulates…”
Get full text
Journal Article -
9
Abstract 5161: The development of therapeutic inhibitors of the KDM5 histone demethylases
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Abstract Histone methyl marks contribute to the regulation of chromatin architecture and of DNA-based processes such as replication, repair and gene…”
Get full text
Journal Article -
10
Control of cell proliferation by Myc
Published in Trends in cell biology (01-05-1998)“…Myc proteins are key regulators of mammalian cell proliferation. They are transcription factors that activate genes as part of a heterodimeric complex with the…”
Get full text
Journal Article -
11
Mutual requirement of CDK4 and Myc in malignant transformation : Evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc
Published in Oncogene (10-07-1997)“…We demonstrate in this paper that CDK4 which is a G1 phase specific cell cycle regulator and catalytic subunit of D-type cyclins has oncogenic activity similar…”
Get full text
Journal Article -
12
An alternative pathway for gene regulation by Myc
Published in The EMBO journal (15-09-1997)“…The c‐Myc protein activates transcription as part of a heteromeric complex with Max. However, Myc‐transformed cells are characterized by loss of expression of…”
Get full text
Journal Article -
13
FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function: FoxO3A inhibits Myc to control hypoxic metabolism
Published in The EMBO journal (16-11-2011)Get full text
Journal Article -
14
The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIFS
Published in The Journal of biological chemistry (26-12-2008)“…Posttranslational histone modifications serve to store epigenetic information and control both nucleosome assembly and recruitment of non-histone proteins…”
Get full text
Journal Article -
15
Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms
Published in Oncogene (17-06-1999)“…The tumor suppressor Bin1 was identified through its interaction with the N-terminal region of Myc which harbors its transcriptional activation domain. Here we…”
Get full text
Journal Article -
16
TGF[beta] influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b
Published in Nature cell biology (01-04-2001)“…Transforming growth factor-beta (TGFbeta) is a cytokine that arrests epithelial cell division by switching off the proto-oncogene c-myc and rapidly switching…”
Get full text
Journal Article -
17
TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b
Published in Nature cell biology (01-04-2001)Get full text
Journal Article -
18
TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15 INK4b
Published in Nature cell biology (01-04-2001)Get full text
Journal Article -
19
Repression of p15 INK4b expression by Myc through association with Miz-1
Published in Nature cell biology (01-04-2001)Get full text
Journal Article -
20
Repression of p15INK4b expression by Myc through association with Miz-1
Published in Nature cell biology (01-04-2001)“…Deregulated expression of c-myc can induce cell proliferation in established cell lines and in primary mouse embryonic fibroblasts (MEFs), through a…”
Get full text
Journal Article